Featured Research

from universities, journals, and other organizations

Approaches to pain assessment in cancer clinical trials

Date:
December 5, 2013
Source:
University of North Carolina School of Medicine
Summary:
Researchers have developed guidelines to help drug developers include meaningful pain endpoints when designing cancer trials.

Pain is a common symptom and can be debilitating for patients with cancer. Clinically significant improvements in pain resulting from a cancer treatment can support drug approval and labeling claims in the United States, when it is adequately measured. Different approaches have been used for measuring pain in cancer clinical trials, with varying levels of rigor.

A new paper published by Cancer External Site describes approaches to pain measurement used in oncology clinical trials submitted to the U.S. Food and Drug Administration that are consistent with current FDA guidance principles. The purpose of the paper is to assist drug developers to include meaningful pain endpoints when designing cancer trials.

"Measurement of pain and other symptoms is an essential part of cancer trials. Without this information, our understanding of how drugs affect people is incomplete," said lead author Ethan Basch, MD, Director of the Cancer Outcomes Research Program at the University of North Carolina Lineberger Comprehensive Cancer Center. Dr. Basch developed the paper with FDA colleagues while serving as a Guest Worker at the FDA.

The paper outlines several areas that are commonly a challenge in pain analyses, including measuring pain and analgesic use, how to collect pain information from patients, and how to define pain improvements. Examples of how the challenges have been addressed in past trials are provided.


Story Source:

The above story is based on materials provided by University of North Carolina School of Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ethan Basch, Ann Marie Trentacosti, Laurie B. Burke, Virginia Kwitkowski, Robert C. Kane, Karen A. Autio, Elektra Papadopoulos, James P. Stansbury, Paul G. Kluetz, Harry Smith, Robert Justice, Richard Pazdur. Pain palliation measurement in cancer clinical trials: The US Food and Drug Administration perspective. Cancer, 2013; DOI: 10.1002/cncr.28470

Cite This Page:

University of North Carolina School of Medicine. "Approaches to pain assessment in cancer clinical trials." ScienceDaily. ScienceDaily, 5 December 2013. <www.sciencedaily.com/releases/2013/12/131205165721.htm>.
University of North Carolina School of Medicine. (2013, December 5). Approaches to pain assessment in cancer clinical trials. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/12/131205165721.htm
University of North Carolina School of Medicine. "Approaches to pain assessment in cancer clinical trials." ScienceDaily. www.sciencedaily.com/releases/2013/12/131205165721.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins